Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

NCT04858776 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Iliofemoral; Thrombosis

Interventions

COMBINATION_PRODUCT: Perivascular dexamethasone
COMBINATION_PRODUCT: Perivascular sham

Sponsor

Mercator MedSystems, Inc.